Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Translational Oncology
|
December 22, 2024
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
Martina Ruglioni, Iacopo Petrini, Stefania Crucitta, et al.
The International Journal of Biological Markers
|
September 30, 2010
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma
Alfonso Cristaudo, Rudy Foddis, Alessandra Bonotti, et al.
Scientific Reports
|
March 7, 2019
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas
Greta Alì, Rossella Bruno, Anello Marcello Poma, et al.
Frontiers in Oncology
|
February 27, 2023
Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer
Greta Alì, Anello Marcello Poma, Iosè Di Stefano, et al.
Pharmacological Research
|
May 3, 2021
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives
Federico Cucchiara, Iacopo Petrini, Chiara Romei, et al.
Frontiers in Oncology
|
January 25, 2021
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
Federico Cucchiara, Marzia Del Re, Simona Valleggi, et al.
International Journal of Molecular Sciences
|
August 17, 2019
Understanding the Mechanisms of Resistance in <i>EGFR</i>-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy
Marzia Del Re, Stefania Crucitta, Giulia Gianfilippo, et al.
The International Journal of Biological Markers
|
September 21, 2016
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma
Alessandra Bonotti, Silvia Simonini, Elena Pantani, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 18, 2002
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation
Antonio Marchetti, Caterina Pellegrini, Fiamma Buttitta, et al.
British Journal of Cancer
|
November 7, 2018
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
Marzia Del Re, Paola Bordi, Eleonora Rofi, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Translational Oncology
|
December 22, 2024
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
Martina Ruglioni, Iacopo Petrini, Stefania Crucitta, et al.
The International Journal of Biological Markers
|
September 30, 2010
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma
Alfonso Cristaudo, Rudy Foddis, Alessandra Bonotti, et al.
Scientific Reports
|
March 7, 2019
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas
Greta Alì, Rossella Bruno, Anello Marcello Poma, et al.
Frontiers in Oncology
|
February 27, 2023
Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer
Greta Alì, Anello Marcello Poma, Iosè Di Stefano, et al.
Pharmacological Research
|
May 3, 2021
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives
Federico Cucchiara, Iacopo Petrini, Chiara Romei, et al.
Frontiers in Oncology
|
January 25, 2021
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
Federico Cucchiara, Marzia Del Re, Simona Valleggi, et al.
International Journal of Molecular Sciences
|
August 17, 2019
Understanding the Mechanisms of Resistance in <i>EGFR</i>-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy
Marzia Del Re, Stefania Crucitta, Giulia Gianfilippo, et al.
The International Journal of Biological Markers
|
September 21, 2016
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma
Alessandra Bonotti, Silvia Simonini, Elena Pantani, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 18, 2002
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation
Antonio Marchetti, Caterina Pellegrini, Fiamma Buttitta, et al.
British Journal of Cancer
|
November 7, 2018
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
Marzia Del Re, Paola Bordi, Eleonora Rofi, et al.
Page
of 12